MXPA03006603A - Agonista de subtipo de receptor 5-ht1a. - Google Patents

Agonista de subtipo de receptor 5-ht1a.

Info

Publication number: MXPA03006603A
Authority: MX; Mexico
Prior art keywords: ht1a
Prior art date: 2001-01-29

Application number

MXPA03006603A

Other languages

English (en)

Inventor

Jordan Shaun

Original Assignee

Otsuka Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-01-29

Filing date

2002-01-29

Publication date

2004-02-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25087808&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA03006603(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-01-29 Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd

2004-02-12 Publication of MXPA03006603A publication Critical patent/MXPA03006603A/es

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Addiction (AREA)
Psychology (AREA)
Reproductive Health (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Endocrinology (AREA)
Anesthesiology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Gynecology & Obstetrics (AREA)
Child & Adolescent Psychology (AREA)
Toxicology (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Quinoline Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

MXPA03006603A 2001-01-29 2002-01-29 Agonista de subtipo de receptor 5-ht1a. MXPA03006603A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US77021001A	2001-01-29	2001-01-29
PCT/JP2002/000626 WO2002060423A2 (en)	2001-01-29	2002-01-29	Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists

Publications (1)

Publication Number	Publication Date
MXPA03006603A true MXPA03006603A (es)	2004-02-12

Family

ID=25087808

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
MX2011010975A MX344556B (es)	2001-01-29	2002-01-29	Agonista de subtipo de receptor 5-ht1a.
MXPA03006603A MXPA03006603A (es)	2001-01-29	2002-01-29	Agonista de subtipo de receptor 5-ht1a.

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
MX2011010975A MX344556B (es)	2001-01-29	2002-01-29	Agonista de subtipo de receptor 5-ht1a.

Country Status (20)

Country	Link
EP (3)	EP1355639B1 (es)
JP (4)	JP4178032B2 (es)
KR (5)	KR100713607B1 (es)
CN (3)	CN100450485C (es)
AR (4)	AR032641A1 (es)
AT (3)	ATE362763T1 (es)
AU (4)	AU2002226752C1 (es)
BR (1)	BR0206237A (es)
CA (2)	CA2700314C (es)
CY (3)	CY1105631T1 (es)
DE (3)	DE60220325T2 (es)
DK (3)	DK1621198T3 (es)
ES (3)	ES2286755T3 (es)
HK (2)	HK1061805A1 (es)
MX (2)	MX344556B (es)
MY (1)	MY129355A (es)
PH (1)	PH12014500937A1 (es)
PT (3)	PT1621198E (es)
TW (2)	TWI331919B (es)
WO (1)	WO2002060423A2 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR032641A1 (es) *	2001-01-29	2003-11-19	Otsuka Pharma Co Ltd	Agonista de subtipo de receptor 5-ht 1a.
US7053092B2 (en)	2001-01-29	2006-05-30	Otsuka Pharmaceutical Co., Ltd.	5-HT1a receptor subtype agonist
US8703772B2 (en)	2001-09-25	2014-04-22	Otsuka Pharmaceutical Co., Ltd.	Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
AR033485A1 (es)	2001-09-25	2003-12-26	Otsuka Pharma Co Ltd	Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
DE10148233A1 (de) *	2001-09-28	2003-04-10	Boehringer Ingelheim Pharma	Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme
US7973043B2 (en) *	2002-07-30	2011-07-05	Peter Migaly	Combination therapy for depression, prevention of suicide, and various medical and psychiatric conditions
AR042806A1 (es) *	2002-12-27	2005-07-06	Otsuka Pharma Co Ltd	Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo
PT1575590E (pt) *	2002-12-27	2007-12-06	Otsuka Pharma Co Ltd	Derivados de carboestirilo e inibidores da reabsorção de serotonina para o tratamento de distúrbios de humor
PL1626721T3 (pl)	2003-05-23	2017-05-31	Otsuka Pharmaceutical Co., Ltd.	Pochodne karbostyrylu i stabilizatory nastroju do leczenia zaburzeń nastroju
US7160888B2 (en)	2003-08-22	2007-01-09	Warner Lambert Company Llc	[1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
FR2865650B1 (fr) *	2004-01-30	2008-06-13	Biocortech	Utilisation du 14,15 dihydro 20,21-dinoreburnamenin14-ol pour traiter et/ou prevenir les depressions majeures et les desordres du cycle veille-sommeil
WO2006090273A2 (en) *	2005-02-22	2006-08-31	Warner-Lambert Company Llc	[1,8]naphthyridin-2-ones and related compounds with keto or hydroxyl linkers for the treatment of schizophrenia
US8227476B2 (en) *	2005-08-03	2012-07-24	Sprout Pharmaceuticals, Inc.	Use of flibanserin in the treatment of obesity
TW200848041A (en) *	2007-03-30	2008-12-16	Otsuka Pharma Co Ltd	A medicament for treating schizophrenia comprising cilostazol
GB2456183A (en)	2008-01-04	2009-07-08	Gw Pharma Ltd	Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament
JP2009286740A (ja) *	2008-05-30	2009-12-10	Otsuka Pharmaceut Co Ltd	アリピプラゾールを含有する逆耐性抑制剤
EP2338873A1 (en)	2009-12-22	2011-06-29	Gmeiner, Peter	New aminotetraline derivatives
AR090245A1 (es)	2012-03-06	2014-10-29	Otsuka Pharma Co Ltd	Preparacion solida oral de liberacion sostenida, metodo de preparacion
JOP20200109A1 (ar)	2012-04-23	2017-06-16	Otsuka Pharma Co Ltd	مستحضر قابل للحقن

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS54130587A (en)	1978-03-30	1979-10-09	Otsuka Pharmaceut Co Ltd	Carbostyryl derivative
JPS5646812A (en) *	1979-09-27	1981-04-28	Otsuka Pharmaceut Co Ltd	Central nervous system depressant
US4764416A (en) *	1986-07-01	1988-08-16	Mitsubishi Denki Kabushiki Kaisha	Electric element circuit using oxidation-reduction substances
US5006528A (en) *	1988-10-31	1991-04-09	Otsuka Pharmaceutical Co., Ltd.	Carbostyril derivatives
JP2608788B2 (ja) *	1988-10-31	1997-05-14	大塚製薬株式会社	精神***病治療剤
ES2103374T3 (es) *	1991-05-20	1997-09-16	Upjohn Co	Derivados de carboxamido-(1,2n)-carbociclo-2-aminotetralina.
US5532240A (en) *	1991-12-26	1996-07-02	Yoshitomi Pharmaceutical Industries, Ltd.	Condensed thiophene compound and pharmaceutical use thereof
AU5446894A (en) *	1992-10-23	1994-05-24	New York University	Functional interactions between glial s-100b and central nervous system serotonergic neurons
DK148292D0 (da) *	1992-12-09	1992-12-09	Lundbeck & Co As H	Forbindelser
JP2959615B2 (ja) *	1993-06-24	1999-10-06	吉富製薬株式会社	縮合型チオフェン化合物およびその医薬用途
JPH09291034A (ja) *	1996-02-27	1997-11-11	Yoshitomi Pharmaceut Ind Ltd	縮合ピリジン化合物およびその医薬としての用途
US5688950A (en) *	1996-04-23	1997-11-18	Neurogen Corporation	Tricyclic aminoalkylcarboxamides; novel dopamine D3 receptor subtype specific ligands
UA47467C2 (uk) *	1996-05-07	2002-07-15	Файзер Інк.	Тригідрат мезилату 5-(2-(4-(1,2-бензизотіазол-3-іл)-1-піперазиніл)етил)-6-хлор-1,3-дигідро-2(1н)-індол-2-ону (зипразидону), фармацевтична композиція та спосіб лікування психічних розладів
JP4012994B2 (ja) *	1996-05-08	2007-11-28	大塚製薬株式会社	抗不安薬
CN1234023A (zh) *	1996-08-27	1999-11-03	美国家用产品公司	作为多巴胺d2激动剂和5ht1a的配位体的4－氨基乙氧基吲哚
CN1289333A (zh) *	1998-02-03	2001-03-28	美国家用产品公司	用作血清素－1a受体激动剂的噁唑衍生物
WO1999052870A1 (en) *	1998-04-13	1999-10-21	American Home Products Corporation	4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists
JPH11335286A (ja) *	1998-05-25	1999-12-07	Mitsui Chem Inc	ドーパミン拮抗薬の効果増強剤
AR032641A1 (es) *	2001-01-29	2003-11-19	Otsuka Pharma Co Ltd	Agonista de subtipo de receptor 5-ht 1a.
EP1627639B1 (en) *	2001-06-19	2009-12-23	Norbert Müller	Use of COX-2 inhibitors for the treatment of affective disorders
AR033485A1 (es) *	2001-09-25	2003-12-26	Otsuka Pharma Co Ltd	Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma

2002
- 2002-01-15 AR ARP020100118A patent/AR032641A1/es not_active Application Discontinuation
- 2002-01-25 TW TW093127321A patent/TWI331919B/zh not_active IP Right Cessation
- 2002-01-25 TW TW091101289A patent/TWI302832B/zh not_active IP Right Cessation
- 2002-01-26 MY MYPI20020297A patent/MY129355A/en unknown
- 2002-01-29 KR KR1020067014046A patent/KR100713607B1/ko active IP Right Grant
- 2002-01-29 PT PT05023971T patent/PT1621198E/pt unknown
- 2002-01-29 ES ES05023971T patent/ES2286755T3/es not_active Expired - Lifetime
- 2002-01-29 MX MX2011010975A patent/MX344556B/es unknown
- 2002-01-29 PT PT02716434T patent/PT1355639E/pt unknown
- 2002-01-29 DE DE60220325T patent/DE60220325T2/de not_active Expired - Lifetime
- 2002-01-29 AT AT05023971T patent/ATE362763T1/de active
- 2002-01-29 EP EP02716434A patent/EP1355639B1/en not_active Expired - Lifetime
- 2002-01-29 KR KR1020057019896A patent/KR100653591B1/ko active IP Right Grant
- 2002-01-29 DK DK05023971T patent/DK1621198T3/da active
- 2002-01-29 PT PT06015782T patent/PT1712225E/pt unknown
- 2002-01-29 AT AT06015782T patent/ATE504293T1/de active
- 2002-01-29 ES ES02716434T patent/ES2261652T3/es not_active Expired - Lifetime
- 2002-01-29 EP EP05023971A patent/EP1621198B1/en not_active Revoked
- 2002-01-29 KR KR1020077010561A patent/KR100825705B1/ko active IP Right Grant
- 2002-01-29 KR KR1020067005164A patent/KR100763288B1/ko active IP Right Review Request
- 2002-01-29 BR BR0206237-2A patent/BR0206237A/pt not_active Application Discontinuation
- 2002-01-29 EP EP06015782A patent/EP1712225B1/en not_active Revoked
- 2002-01-29 WO PCT/JP2002/000626 patent/WO2002060423A2/en active Application Filing
- 2002-01-29 DK DK06015782.3T patent/DK1712225T3/da active
- 2002-01-29 KR KR1020037008565A patent/KR100601073B1/ko active IP Right Grant
- 2002-01-29 ES ES06015782T patent/ES2363366T3/es not_active Expired - Lifetime
- 2002-01-29 DE DE60210581T patent/DE60210581T2/de not_active Expired - Lifetime
- 2002-01-29 DK DK02716434T patent/DK1355639T3/da active
- 2002-01-29 MX MXPA03006603A patent/MXPA03006603A/es active IP Right Grant
- 2002-01-29 JP JP2002560616A patent/JP4178032B2/ja not_active Expired - Lifetime
- 2002-01-29 CA CA2700314A patent/CA2700314C/en not_active Expired - Lifetime
- 2002-01-29 CN CNB2005100228288A patent/CN100450485C/zh not_active Expired - Lifetime
- 2002-01-29 AT AT02716434T patent/ATE322894T1/de active
- 2002-01-29 DE DE60239711T patent/DE60239711D1/de not_active Expired - Lifetime
- 2002-01-29 AU AU2002226752A patent/AU2002226752C1/en not_active Expired
- 2002-01-29 CA CA2429496A patent/CA2429496C/en not_active Expired - Lifetime
- 2002-01-29 CN CNA2006100943881A patent/CN1879624A/zh active Pending
- 2002-01-29 CN CNB028035518A patent/CN1239154C/zh not_active Expired - Lifetime
2004
- 2004-07-06 HK HK04104847A patent/HK1061805A1/xx not_active IP Right Cessation
2005
- 2005-04-27 AU AU2005201772A patent/AU2005201772C1/en not_active Expired
2006
- 2006-06-28 CY CY20061100884T patent/CY1105631T1/el unknown
- 2006-11-01 HK HK06111985.8A patent/HK1091403A1/xx not_active IP Right Cessation
2007
- 2007-04-17 AU AU2007201701A patent/AU2007201701B2/en not_active Expired
- 2007-07-09 JP JP2007179275A patent/JP4896831B2/ja not_active Expired - Lifetime
- 2007-08-20 CY CY20071101093T patent/CY1108031T1/el unknown
2009
- 2009-10-29 AU AU2009233591A patent/AU2009233591B2/en not_active Expired
2010
- 2010-12-28 AR ARP100104973A patent/AR079761A2/es not_active Application Discontinuation
2011
- 2011-04-08 AR ARP110101189A patent/AR080849A2/es not_active Application Discontinuation
- 2011-04-18 CY CY20111100391T patent/CY1111392T1/el unknown
- 2011-06-15 JP JP2011133033A patent/JP2011184460A/ja active Pending
- 2011-06-15 JP JP2011133032A patent/JP5683010B2/ja not_active Expired - Lifetime
2014
- 2014-04-28 PH PH12014500937A patent/PH12014500937A1/en unknown
2015
- 2015-03-13 AR ARP150100766A patent/AR099754A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
AR099754A2 (es)	2016-08-17
KR100763288B1 (ko)	2007-10-04
ES2261652T3 (es)	2006-11-16
CN1239154C (zh)	2006-02-01
CA2700314C (en)	2012-04-24
MX344556B (es)	2016-12-20
CN1879624A (zh)	2006-12-20
CY1108031T1 (el)	2013-09-04
JP4896831B2 (ja)	2012-03-14
AU2007201701B2 (en)	2010-06-17
KR100601073B1 (ko)	2006-07-19
JP4178032B2 (ja)	2008-11-12
DE60210581D1 (en)	2006-05-24
HK1091403A1 (en)	2007-01-19
EP1355639B1 (en)	2006-04-12
CN1813745A (zh)	2006-08-09
PT1712225E (pt)	2011-04-18
JP2011225587A (ja)	2011-11-10
DK1621198T3 (da)	2007-09-24
KR20050107822A (ko)	2005-11-15
ES2286755T3 (es)	2007-12-01
AR079761A2 (es)	2012-02-15
AU2009233591B2 (en)	2011-10-20
CA2429496A1 (en)	2002-08-08
JP2011184460A (ja)	2011-09-22
WO2002060423A2 (en)	2002-08-08
CN1484524A (zh)	2004-03-24
AU2005201772B2 (en)	2007-05-17
BR0206237A (pt)	2003-12-23
MY129355A (en)	2007-03-30
DE60210581T2 (de)	2007-04-05
HK1061805A1 (en)	2004-10-08
ATE504293T1 (de)	2011-04-15
EP1712225B1 (en)	2011-04-06
AU2009233591A1 (en)	2009-11-19
AU2002226752B2 (en)	2005-03-17
KR20060085260A (ko)	2006-07-26
EP1621198A2 (en)	2006-02-01
KR100713607B1 (ko)	2007-05-02
EP1621198A3 (en)	2006-04-12
KR20060028485A (ko)	2006-03-29
KR20070065425A (ko)	2007-06-22
AR032641A1 (es)	2003-11-19
EP1355639A2 (en)	2003-10-29
EP1712225A1 (en)	2006-10-18
JP2004517937A (ja)	2004-06-17
CA2429496C (en)	2010-10-19
EP1621198B1 (en)	2007-05-23
CA2700314A1 (en)	2002-08-08
PT1621198E (pt)	2007-06-08
KR100653591B1 (ko)	2006-12-05
TWI331919B (en)	2010-10-21
CN100450485C (zh)	2009-01-14
JP5683010B2 (ja)	2015-03-11
KR20030065570A (ko)	2003-08-06
CY1105631T1 (el)	2010-12-22
AR080849A2 (es)	2012-05-09
KR100825705B1 (ko)	2008-04-29
DK1355639T3 (da)	2006-08-14
ES2363366T3 (es)	2011-08-02
DE60220325D1 (de)	2007-07-05
AU2007201701A1 (en)	2007-05-10
DE60239711D1 (de)	2011-05-19
JP2007297405A (ja)	2007-11-15
DK1712225T3 (da)	2011-06-20
DE60220325T2 (de)	2008-01-17
PT1355639E (pt)	2006-06-30
WO2002060423A3 (en)	2003-04-10
PH12014500937A1 (en)	2015-09-21
ATE322894T1 (de)	2006-04-15
AU2002226752C1 (en)	2010-02-18
TW200522960A (en)	2005-07-16
AU2005201772C1 (en)	2010-06-03
AU2005201772A1 (en)	2005-05-19
TWI302832B (en)	2008-11-11
CY1111392T1 (el)	2015-08-05
ATE362763T1 (de)	2007-06-15

Legal Events

Date	Code	Title	Description
2007-05-15	FG	Grant or registration

Publication	Publication Date	Title
ZA200208561B (en)	2003-05-19	Hydraulischer druckverstarker.
MXPA03007093A (es)	2003-11-18	Nueva composicion.
MXPA03007166A (es)	2003-11-18	Pirido-pirimidinas 6-sustituidas.
MXPA03009558A (es)	2004-02-12	Compuestos novedosos.
ZA200303135B (en)	2004-07-23	Foodstuff.
MXPA01009037A (es)	2003-11-18	I-bet.
MXPA03009583A (es)	2004-02-12	Ftalazinonas novedosas.
MXPA03006603A (es)	2004-02-12	Agonista de subtipo de receptor 5-ht1a.
HK1048241A1 (en)	2003-03-28	Fryer.
ZA200308133B (en)	2004-06-04	Sulfonamides.
MXPA03007693A (es)	2003-12-04	Composicion para la piel.
ZA200208648B (en)	2003-10-27	Metal-polyurethane laminates.
MXPA03005286A (es)	2003-10-06	METODO Y APARATO PARA SUPERVISAR PULSACION DE INSTALACION DE ORDEnA.
MXPA03008140A (es)	2003-12-12	Amidas de acido benzofuran-2-carboxilico sustituidas.
MXPA03008139A (es)	2003-12-12	Fluoralcoxifenilsulfonilureas sustituidas.
HK1049770A1 (en)	2003-05-30	Fan.
EG23378A (en)	2005-02-28	Composition.
IL162310A0 (en)	2005-11-20	3,4-Dihydro-1h-isoquinoloin-2-yl-derivatives
MXPA03008394A (es)	2004-01-29	Derivados de biuretano.
MXPA03008077A (es)	2003-12-12	Composicion humedecedora para la piel..
HK1059781A1 (en)	2004-07-16	New phenylpiperazines.
MXPA03007888A (es)	2003-12-04	Compuestos para tratamiento y prevencion de ulcera gastrica inducida por medicamentos.
HK1060608A1 (en)	2004-08-13	Latch.
AP2001000098S (en)	2003-06-06	Marimbira.
MXPA01005710A (es)	2003-08-20	Losa-cimbra.